发明名称 |
METHOD FOR INDIVIDUALIZED DRUG THERAPY |
摘要 |
Methods for individualized therapy of arthritic pain using a non-steroidal anti-inflammatory drug (NSAID). Said methods comprise basing NSAID dose on each patient's pharmacokinetic and pharmacodynamic response to said NSAID. |
申请公布号 |
US2016199392(A1) |
申请公布日期 |
2016.07.14 |
申请号 |
US201514595823 |
申请日期 |
2015.01.13 |
申请人 |
Autotelic LLC |
发明人 |
Trieu Vuong |
分类号 |
A61K31/60;A61K45/06;A61K31/415 |
主分类号 |
A61K31/60 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for individualized therapy of arthritic pain using celecoxib, comprising:
a. orally administering a first celecoxib formulation comprising 100 mg of celecoxib to a patient suffering from arthritic pain; b. determining the celecoxib concentration in the patient's blood at a plurality of time points after the first celecoxib formulation was administered to the patient; c. transforming the patient's celecoxib concentration/time data points in to one or more pharmacokinetic (PK) parameters; d. determining the patient's clinical response to the first celecoxib formulation comprising 100 mg of celecoxib and
i. if pain control is not adequate repeat steps a-c with a higher celecoxib dose;ii if toxicity is not tolerable repeat steps a-c with a lower celecoxib dose;iii. if pain control is adequate and toxicity is tolerable determine the then present value for one or more pharmacokinetic (PK) parameters; and e. maintaining the patient on the celecoxib formulation at a celecoxib dose and frequency of administration that results in the value for the one or more pharmacokinetic (PK) parameters determined in step d (iii). |
地址 |
City of Industry CA US |